Top

Published in:

01-09-2000 | ORIGINAL ARTICLE

Feasibility of a novel weekday-on/weekend-off oral UFT schedule as postoperative adjuvant chemotherapy for colorectal cancer

Authors: Sotaro Sadahiro, Shigeru Ohki, Shigeki Yamaguchi, Toshiki Takahashi, Yoshimasa Otani, Satoshi Tsukikawa, Takuya Yamamura, Shoji Takemiya, Hideaki Nagasaki, Kiyoshi Nishiyama, Tsuneo Fukushima, Yoshiki Hiki, Susumu Yamaguchi, Kaoru Kumada, Hiroshi Shimada, Toshio Mitomi, Hiroyasu Makuuchi

Published in: Cancer Chemotherapy and Pharmacology | Issue 3/2000

Title: Feasibility of a novel weekday-on/weekend-off oral UFT schedule as postoperative adjuvant chemotherapy for colorectal cancer
Authors: Sotaro Sadahiro
Shigeru Ohki
Shigeki Yamaguchi
Toshiki Takahashi
Yoshimasa Otani
Satoshi Tsukikawa
Takuya Yamamura
Shoji Takemiya
Hideaki Nagasaki
Kiyoshi Nishiyama
Tsuneo Fukushima
Yoshiki Hiki
Susumu Yamaguchi
Kaoru Kumada
Hiroshi Shimada
Toshio Mitomi
Hiroyasu Makuuchi
Publication date: 01-09-2000
Publisher: Springer-Verlag
Published in: Cancer Chemotherapy and Pharmacology / Issue 3/2000
Print ISSN: 0344-5704
Electronic ISSN: 1432-0843
DOI: https://doi.org/10.1007/s002800000146

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 3/2000

Phase I dose escalation pharmacokinetics of O-(chloroacetylcarbamoyl) fumagillol (TNP-470) and its metabolites in AIDS patients with Kaposi's sarcoma

Effect of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on plasma concentration of uridine released from 2′,3′,5′-tri-O-acetyluridine, a prodrug of uridine: relevance to uridine rescue in chemotherapy

A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancer

Population pharmacokinetics of pemetrexed disodium (ALIMTA) in patients with cancer

Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer

Modified irinotecan hydrochloride (CPT-11) administration schedule improves induction of delayed-onset diarrhea in rats

Keynote webinar | Spotlight on antibody–drug conjugates in cancer